Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Lymphoma
- Urological Cancers
- Colorectal Cancer
- Brain and Spinal Cord Cancer
- Head and Neck Oncology
- Sarcomas
- Melanoma/Skin Cancer
- Chemotherapy and Radiotherapy
Abstract
Citation: Clin Oncol. 2016;1(1):1114.DOI: 10.25107/2474-1663.1114
Pancytopenia and Neuroendocrine Small Cell Carcinoma of the Bladder
Irache Abáigar-Pedraza, Juan Pablo Caballero-Romeu, Estela Costa and Juan Francisco Galiano-Baena
Department of Urology, General University Alicante's Hospital, Spain
Department of Anatomo Pathology, General University Alicante's Hospital, Spain
*Correspondance to: Irache Ab�igar-Pedraza
PDF Full Text Case Report | Open Access
Abstract:
Clinical Practice: Small cell neuroendocrine tumor of the bladder is a rare aggressive tumor with high metastatic potential. Despite aggressive multi-modal treatment, it has a high mortality rate. Tumor infiltration of the bone marrow, myelophthisis, is uncommon and has a devastating prognosis. This is the second case described in scientific literature. In patients with bladder carcinoma and an alteration in any of the three blood series (red cells, white cells, platelets) that do not respond to transfusion, infiltration of the bone marrow must be established.
Keywords:
Small cell neuroendocrine carcinoma of the bladder and myelophthisic anemia
Cite the Article:
Abáigar-Pedraza I, Caballero-Romeu JP, Costa E, Galiano-Baena JF. Pancytopenia and Neuroendocrine Small Cell Carcinoma of the Bladder. Clin Oncol. 2016; 1: 1114.